Loading organizations...
Colorcon Ventures is the strategic investment arm of Colorcon, fostering innovation within the pharmaceutical and nutraceutical sectors. It invests in technologies enhancing patient compliance, dosage form authentication, and drug delivery. The firm also backs intelligent systems for digital and personalized medicine, and manufacturing/supply chain advancements.
Established by Colorcon, a global leader in pharmaceutical excipients and coating systems, the initiative leverages its parent company’s extensive industry insight. This stems from a belief that external innovation complements Colorcon’s core capabilities, addressing evolving needs and driving broader industry progress in health and nutrition.
The firm partners with early and mid-stage startups developing transformative solutions. Beyond capital, it provides strategic consultation, commercial guidance, and scientific development support to its portfolio. Its vision is to accelerate growth, ultimately shaping the future of pharmaceutical and nutraceutical applications.
Colorcon Ventures has 5 tracked investments across 4 companies. The latest tracked deal is $38.0M Grant / Series A in Syntis Bio in July 2025.